Cargando…
Immunotherapy and Antivascular Targeted Therapy in Patients' Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge
OBJECTIVE: To analyze the therapeutic effects and organ rejection of anti-PD-1 immunotherapy or antivascular targeting therapy on patients with combined malignancies after organ transplantation. METHODS: We collected retrospective studies on “post-transplantation, cancer, immunotherapy, and vascular...
Autores principales: | Shen, Bairu, Guo, Zi, Huang, Peng, Tan, Minghua, Zhang, Xiaoshen, Lin, Siyao, Song, Changshan, Wang, Jiaqing, Huang, Minqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184147/ https://www.ncbi.nlm.nih.gov/pubmed/35692497 http://dx.doi.org/10.1155/2022/6440419 |
Ejemplares similares
-
Current Status of Malignant Tumors after Organ Transplantation
por: Shen, Bairu, et al.
Publicado: (2022) -
Diosmetin Affects Gene Expression on Human Lung Adenocarcinoma Cells
por: Song, Changshan, et al.
Publicado: (2022) -
The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion
por: Shen, Bairu, et al.
Publicado: (2022) -
HDAC4 Inhibitors as Antivascular Senescence Therapeutics
por: Huang, Chuoji, et al.
Publicado: (2022) -
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
por: Ma, Xiaocong, et al.
Publicado: (2023)